⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqGS

INCY

Incyte Corporation

Healthcare · Biotechnology

126.01USD

+1.6100 (+1.29%)

DescriptionHistoricalFinancialsRelative ValueResearchNewsDiscussionOptionsPrice Chart ↗Fundamental Chart ↗

Estimates and surprises

Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.

PeriodConsensus EPS90 days agoRevisions up (30d)Revisions down (30d)
Current quarter$-3.47▼$2.0108
Next quarter$1.95▼$2.135
Current year$3.46▼$7.71011
Next year$8.89▼$9.0729

Recent quarters

Beat in 3 of the last 4

QuarterEstimateActualSurprise
2026-06-30$2.15$3.09+0.94 (+43.9%)
2026-03-31$1.34$1.81+0.47 (+35.1%)
2025-12-31$1.92$1.8-0.12 (-6.1%)
2025-09-30$1.64$2.26+0.62 (+38.0%)

Wall Street coverage

349 ratings from 41 firms

Ratings are attributed to the research firm, not to individual analysts. See every ticker.

FirmActionRatingPrice TargetDate
Canaccord GenuityInitiatedBuy$152Aug 20, 2026
HC Wainwright & Co.ReiteratedBuy$150Aug 20, 2026
Piper SandlerMaintainedOverweight$110 $130Aug 17, 2026
MizuhoMaintainedOutperform$121 $137Aug 4, 2026
Leerink PartnersMaintainedOutperform$131 $155Aug 3, 2026
HC Wainwright & Co.ReiteratedBuy$150Aug 3, 2026
RBC CapitalMaintainedSector Perform$99 $109Jul 29, 2026
GuggenheimMaintainedBuy$136 $150Jul 29, 2026
BMO CapitalMaintainedMarket Perform$112 $130Jul 29, 2026
BarclaysMaintainedOverweight$134 $139Jul 29, 2026
HC Wainwright & Co.MaintainedBuy$140 $150Jul 29, 2026
JP MorganMaintainedNeutral$105 $110Jul 23, 2026
Morgan StanleyMaintainedEqual-Weight$103 $104Jul 23, 2026
HC Wainwright & Co.ReiteratedBuy$140Jul 21, 2026
BarclaysMaintainedOverweight$117 $134Jul 14, 2026
BMO CapitalMaintainedMarket Perform$94 $112Jul 13, 2026
RBC CapitalMaintainedSector Perform$95 $99Jul 7, 2026
HC Wainwright & Co.ReiteratedBuy$140Jun 29, 2026
UBSMaintainedNeutral$103 $113Jun 26, 2026
HC Wainwright & Co.ReiteratedBuy$140Jun 24, 2026
Truist SecuritiesMaintainedHold$103 $105Jun 22, 2026
BMO CapitalUpgraded from UnderperformMarket Perform$75 $94Jun 22, 2026
HC Wainwright & Co.MaintainedBuy$135 $140Jun 9, 2026
BernsteinInitiatedMarket Perform$99May 22, 2026
HC Wainwright & Co.ReiteratedBuy$135May 21, 2026

Insider transactions

151 filings from 28 insiders · 36 buy / 14 sell over 6m

Officers and directors of INCY, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.

InsiderActionSharesPriceValueDate
CAGNONI PABLO JOfficerSell10.8k$125.56$1.36MAug 19, 2026
CAGNONI PABLO JOfficerSell10.8k$120.04$1.30MAug 12, 2026
MAYES PATRICK AOfficerSell2.2k$123.99$274kAug 5, 2026
CAGNONI PABLO JPresidentSell10.6k$122.69$1.31MAug 5, 2026
MAYES PATRICK AOfficerExercise2.2k$106.47$235kAug 5, 2026
MAYES PATRICK AOfficerSell48.0k$119.38$5.73MAug 3, 2026
MAYES PATRICK AOfficerExercise45.8k$61.18$3.59MAug 3, 2026
CAGNONI PABLO JOfficerSell15.9k$119.70$1.90MJul 31, 2026
STEIN STEVEN H.OfficerSell1.9k$114.73$215kJul 16, 2026
ISSA MOHAMED KHAIRIEOfficerSell1.1k$115.01$126kJul 16, 2026
HOFFMAN RICHARD AGeneral CounselGrant7.4k——Jul 16, 2026
TRAY THOMAS ROfficerGrant2.8k——Jul 16, 2026
ISSA MOHAMED KHAIRIEOfficerGrant7.9k——Jul 16, 2026
MAYES PATRICK AOfficerGrant5.9k——Jul 16, 2026
BASI RAMITPAL KOfficerGrant5.0k——Jul 16, 2026
GARDNER DAVID HOfficerGrant7.4k——Jul 16, 2026
STEIN STEVEN H.OfficerGrant9.8k——Jul 16, 2026
CAGNONI PABLO JPresidentGrant13.4k——Jul 16, 2026
MEURY WILLIAMChief Executive OfficerGrant26.8k——Jul 16, 2026
STEIN STEVEN H.OfficerSell28.2k$113.05$3.19MJul 15, 2026

Analyst Notes

Sign in to write

No analyst notes on INCY yet.

Analyst Ratings

23 analysts covering

PeriodStrong BuyBuyHoldSellStrong SellConsensus
Current2101510Hold2.54
1 mo ago2101510Hold2.54
2 mo ago291510Hold2.56
3 mo ago291410Hold2.54
Price target$127.74$86.00 – $155.00
+1.4% to target